A Comparative Wear Test of Two Adhesives on the Unilect ™ Biotab Short Term Monitoring Electrode

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2012 by ConvaTec Inc..
Recruitment status was  Not yet recruiting
Information provided by (Responsible Party):
ConvaTec Inc.
ClinicalTrials.gov Identifier:
First received: May 1, 2012
Last updated: May 2, 2012
Last verified: May 2012
It is hypothesised that the adhesion of electrodes and acceptability of the Electrocardiogram (ECG) trace is comparable between the two groups (marketed and test products) after 30 minutes (the intended period of use) of the electrodes.

Condition Intervention Phase
Healthy Subjects
Device: Marketed electrode
Device: Modified "test" electrode
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: A Comparative Wear Test of Two Adhesives on the Unilect ™ Biotab Short Term Monitoring Electrode

Further study details as provided by ConvaTec Inc.:

Primary Outcome Measures:
  • Product Performance : Remain in place [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
    Ability to remain in place for a duration of 30 minutes (as per intended use)

  • Product Performance: Perform [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
    Ability of the electrodes to perform after a duration of 30 minutes of wear (ECG tracing) as per intended use.

Secondary Outcome Measures:
  • Safety: Adverse Events [ Time Frame: 2 days ] [ Designated as safety issue: No ]
    Safety will be evaluated by the nature and frequency of adverse events, (including condition of the skin under the electrodes using the Skin Irritation Scale (Appendix 4)) and ease of removal

  • Skin Rating [ Time Frame: 2 days ] [ Designated as safety issue: No ]
    Condition of the skin under the electrodes using the Skin Irritation Scale

Estimated Enrollment: 20
Study Start Date: June 2012
Estimated Study Completion Date: June 2012
Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Marketed electrode
The currently marketed electrodes using the current CE marked adhesive
Device: Marketed electrode
12 electrodes will be placed on the subject for an ECG reading to be taken
Active Comparator: Modified hydrogel
Electrodes with the new modified adhesive - the "test" electrodes
Device: Modified "test" electrode
12 electrodes with modified adhesive will be placed on the subject to allow an ECG reading to be taken


Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Provide written informed consent
  • Be a healthy volunteer and be over 18 years of age
  • Willing to attend two scheduled visits for application and removal of the device and adverse event review
  • Have healthy unbroken skin

Exclusion Criteria:

  • Subjects with a history of sensitivity to any one of the components of the device being studied
  • Subjects who have a history of skin related disorders to the chest.
  • Subjects who are actively involved in the development, manufacturing, quality and marketing of Unomedical electrodes
  • Subjects who have any other medical condition which, according to the investigator justifies exclusion from the study
  • Subjects who have any current cardiac conditions that may lead to an abnormal ECG trace
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01590368

Sponsors and Collaborators
ConvaTec Inc.
Principal Investigator: Barbara A Schofield North Cheshire Hospital
  More Information

Responsible Party: ConvaTec Inc.
ClinicalTrials.gov Identifier: NCT01590368     History of Changes
Other Study ID Numbers: UM-1015-12-U365 
Study First Received: May 1, 2012
Last Updated: May 2, 2012
Health Authority: United Kingdom: Medicines and Healthcare Products Regulatory Agency

ClinicalTrials.gov processed this record on May 26, 2016